<\/p>\n
Camzyos<\/strong>, generic mavacamten<\/strong>, is the first approved cardiac myosin inhibitor<\/strong>, used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)<\/strong>. It works by reducing excessive contraction of heart muscle, improving symptoms and activity tolerance<\/p>\n <\/p>\n Active Molecule<\/strong>: Mavacamten<\/p>\n<\/li>\n Drug Class<\/strong>: Cardiac myosin inhibitor; selectively modulates myosin heads to alleviate hypercontractility<\/p>\n<\/li>\n Formulation<\/strong>: Oral capsules<\/p>\n<\/li>\n Approved For<\/strong>: Adults with NYHA Class II\u2013III obstructive HCM<\/strong><\/p>\n<\/li>\n<\/ul>\n Usual Dose<\/strong>: Once-daily oral dose (strength personalized based on individual patient assessment; typical dosing starts at 5\u202fmg\/day and is titrated by echocardiogram)<\/p>\n<\/li>\n Monitoring<\/strong>:<\/p>\n Requires specialized titration based on echocardiographic findings<\/strong><\/p>\n<\/li>\n Available only through the Camzyos REMS Program<\/strong>, which mandates certified providers, pharmacies, and patients<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n <\/p>\n Dizziness<\/strong>, syncope<\/p>\n<\/li>\n Headache<\/strong>, fatigue<\/p>\n<\/li>\n Shortness of breath<\/strong> Heart failure due to systolic dysfunction<\/strong><\/p>\n<\/li>\n<\/ul>\n <\/p>\n Heart failure<\/strong> risk: performance must be monitored closely; discontinue if LVEF becomes dangerously low<\/p>\n<\/li>\n REMS program<\/strong>: Only accessible via certified clinicians, pharmacies, and patients, with regular echocardiographic monitoring<\/p>\n<\/li>\n<\/ul>\n <\/p>\n Camzyos (mavacamten)<\/strong> represents a novel, targeted treatment for symptomatic obstructive HCM, with the unique ability to directly modulate cardiac myosin function. Its use requires specialized monitoring and enrollment in a controlled REMS program due to the serious risk of heart failure. Ongoing monitoring ensures safety and optimal therapeutic benefit.<\/p>\n","protected":false},"excerpt":{"rendered":"
\n\ud83d\udc8a Composition \/ Salt<\/h2>\n
\n
\n\ud83d\udcdd Dosage & Administration<\/h2>\n
\n
\n
\n\u26a0\ufe0f Side Effects<\/h2>\n
\u00a0 \u00a0 Common:<\/h3>\n
\n
\n<\/p>\n<\/li>\n<\/ul>\n\u00a0 \u00a0 \u00a0Serious Risk:<\/h3>\n
\n
\n\ud83d\udea8 Warnings & Precautions<\/h2>\n
\n
\n\u2705 Conclusion<\/h2>\n
\u00a0 \u00a0 Camzyos<\/h1>\n
\n